Trust Investment Advisors Abb Vie Inc. Transaction History

Trust Investment Advisors

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$154.79 - $180.76 $218,718 - $255,413	1,413 New	1,413 $242,000
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $222,699 - $256,471	-1,540 Reduced 13.03%	10,275 $1.64 Million
Q4 2022 Feb 28, 2023	SELL	$138.31 - $165.87 $898,461 - $1.08 Million	-6,496 Reduced 35.48%	11,815 $1.91 Million
Q4 2022 Feb 08, 2023	BUY	$138.31 - $165.87 $1.13 Million - $1.36 Million	8,172 Added 80.6%	18,311 $2.96 Million
Q3 2022 Nov 02, 2022	SELL	$134.21 - $153.93 $28,989 - $33,248	-216 Reduced 2.09%	10,139 $1.36 Million
Q2 2022 Jul 22, 2022	SELL	$137.62 - $174.96 $688 - $874	-5 Reduced 0.05%	10,355 $1.59 Million
Q1 2022 May 02, 2022	BUY	$131.98 - $163.75 $15,045 - $18,667	114 Added 1.11%	10,360 $1.68 Million
Q4 2021 Feb 02, 2022	BUY	$107.43 - $135.93 $11,602 - $14,680	108 Added 1.07%	10,246 $1.39 Million
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $27,557 - $31,282	-259 Reduced 2.49%	10,138 $1.09 Million
Q2 2021 Jul 23, 2021	BUY	$105.21 - $117.21 $54,603 - $60,831	519 Added 5.25%	10,397 $1.17 Million
Q1 2021 May 06, 2021	BUY	$102.3 - $112.62 $135,547 - $149,221	1,325 Added 15.49%	9,878 $1.07 Million
Q4 2020 Feb 05, 2021	BUY	$80.49 - $108.67 $688,430 - $929,454	8,553 New	8,553 $916,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Trust Investment Advisors, based on Form 13F filings with the SEC.

Stay updated on Trust Investment Advisors with notifications on news.